Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Escherichia coli (E. coli) has emerged as a promising adjunct to immune checkpoint inhibitors (ICIs), enhancing their efficacy through microbiome modulation, tumor microenvironment (TME) remodeling, and targeted immune activation.
E. coli–Specific Memory Follicular B Helper T Cells (Tfh) and B-cell Responses Are Associated with Clinical Benefit to Neoadjuvant Pembrolizumab
[Follicular B Helper T Cells (Tfh)](brain://JoIhmzPNcUyCkj9…